117 related articles for article (PubMed ID: 2511705)
1. [Hormonal changes in buserelin therapy].
Fuchs U; Zwirner M
Zentralbl Gynakol; 1989; 111(18):1236-40. PubMed ID: 2511705
[TBL] [Abstract][Full Text] [Related]
2. [Androgens and other hormones in buserelin therapy].
Fuchs U; Zwirner M
Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):140-2. PubMed ID: 1904040
[TBL] [Abstract][Full Text] [Related]
3. [Initial results in the treatment of endometriosis with the LH-RH analog buserelin].
Hardt W; Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Genz T; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):483-9. PubMed ID: 3093311
[TBL] [Abstract][Full Text] [Related]
4. Sex steroid levels during treatment of endometriosis.
Hirschowitz JS; Soler NG; Wortsman J
Obstet Gynecol; 1979 Oct; 54(4):448-50. PubMed ID: 492624
[TBL] [Abstract][Full Text] [Related]
5. [Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies].
Raitz von Frentz M; Schweppe KW
Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):634-9. PubMed ID: 2145192
[TBL] [Abstract][Full Text] [Related]
6. CA-125 monitored therapy with GnRH analogue of pelvic endometriosis.
Negri P; Ricciardelli MA; Tomasi A; Grechi E; Fortini RM
Acta Eur Fertil; 1992; 23(4):171-4. PubMed ID: 1343472
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
Schindler AE; Bühler K; Mettler L; Fuchs U; Cirkel U; Ochs H; Schweppe KW; Koch R
Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):569-73. PubMed ID: 8001754
[TBL] [Abstract][Full Text] [Related]
8. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis.
Rannevik G
Postgrad Med J; 1979; 55 Suppl 5():14-20. PubMed ID: 537948
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experiences in the treatment of endometriosis with the LH-RH analog buserelin with special reference to the post-therapy course].
Schmidt-Gollwitzer K; Schönegg W; von Holleben H; Hardt W; Nevinny-Stickel J
Wien Med Wochenschr; 1988 Nov; 138(21):552-6. PubMed ID: 3144097
[TBL] [Abstract][Full Text] [Related]
10. [The effect of buserelin therapy in endometriosis].
Fuchs U
Zentralbl Gynakol; 1989; 111(18):1231-5. PubMed ID: 2531520
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the GnRH analog buserelin on sex hormone serum level in relation to treatment onset and duration].
Urbancsek J; Rabe T; Gör U; Schulte B; Grunwald K; Papp Z; Runnebaum B
Geburtshilfe Frauenheilkd; 1991 Aug; 51(8):617-25. PubMed ID: 1834511
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women.
Santoro N; Lo Y; Moskaleva G; Arnsten JH; Floris-Moore M; Howard AA; Adel G; Zeitlian G; Schoenbaum EE
Menopause; 2007; 14(5):859-65. PubMed ID: 17415019
[TBL] [Abstract][Full Text] [Related]
13. Hormonal changes associated with Danazol therapy.
Wood GP; Wu CH; Flickinger GL; Mikhail G
Obstet Gynecol; 1975 Mar; 45(3):302-4. PubMed ID: 1113947
[TBL] [Abstract][Full Text] [Related]
14. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A
Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic findings and hormonal patterns in the treatment of endometriosis by danazol.
Tolino A; Romano L; Chiacchio G; Ronsini S; Montemagno U
Acta Eur Fertil; 1987; 18(2):85-9. PubMed ID: 2957884
[TBL] [Abstract][Full Text] [Related]
16. Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).
Cirkel U; Schweppe KW; Ochs H; Schneider HP
Prog Clin Biol Res; 1986; 225():189-99. PubMed ID: 3097665
[No Abstract] [Full Text] [Related]
17. Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
Minaguchi H; Uemura T; Shirasu K
Prog Clin Biol Res; 1986; 225():211-25. PubMed ID: 3097667
[No Abstract] [Full Text] [Related]
18. Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
Shaw RW; Matta W
Clin Reprod Fertil; 1986 Oct; 4(5):329-36. PubMed ID: 3100012
[TBL] [Abstract][Full Text] [Related]
19. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
20. Treatment of endometriosis with gonadotropin releasing hormone agonist (buserelin).
Sirimongkolkasem R; Rojanasakul A; Chailurkit LO
J Med Assoc Thai; 1990 Feb; 73 Suppl 1():37-41. PubMed ID: 2112582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
